Docetaxel Structural Formula (Doc09 0000 01)
Docetaxel Anhydrous Injection, Solution
Product Images NDC 71288-144
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Docetaxel Anhydrous (NDC 71288-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Doc09 0000 02)
Figure 2 (Doc09 0000 03)
Figure 3 (Doc09 0000 04)
This appears to be a graph or chart display description related to survival time in months and cumulative probability.*
Figure 4 (Doc09 0000 05)
This text appears to be a graph or chart related to the "Cumulative Probability" of "Survival Time" in months. Without the graph or chart, it is difficult to provide a more detailed description.*
Figure 5 (Doc09 0000 06)
Figure 6 (Doc09 0000 07)
Figure 7 (Doc09 0000 08)
Figure 8 (Doc09 0000 09)
Figure 9 (Doc09 0000 10)
Figure 10 (Doc09 0000 11)
The data seems to be a survival analysis and compares two groups of patients labeled "TPF" and "PF". The number of patients in each group is given with their survival time in months also shown in the table. However, with the given text formatting, it is difficult to determine the precise meaning of the numbers and graph axes.*
Principal Display Panel – Docetaxel Injection, Usp 8 mL Vial Label (Doc09 0000 14)
Principal Display Panel – Docetaxel Injection, Usp 8 mL Carton (Doc09 0000 15)
The text describes a pharmaceutical product called Docetaxel Injection. It is a cytotoxic agent that is ready to add to an infusion solution, and its usual dosage should be followed to ensure its effectiveness. It comes in a mult-dose vial and should be retained in its original package to protect it from light. Its container and closure are not made with natural rubber latex. It is sterile, nonpyrogenic, and preservative-free. Docetaxel Injection should be stored between 2° and 8°C and protected from light. The concentration of the product should be checked before preparation. It contains 10mg of Docetaxel, 260mg of Plysarate BONE, 4mg of Aycrous Gtic Ad USP, 23%v of dehydrated alcohol US and some amounts of Pojettylene Gycal 00N. The text also provides the manufacturer's details and drug administration warnings.*
Principal Display Panel – Docetaxel Injection, Usp 16 mL Vial Label (Doc09 0000 16)
Principal Display Panel – Docetaxel Injection, Usp 16 mL Carton (Doc09 0000 17)
This is a drug description for Docetaxel injection, which is used for intravenous use only. It comes in a mult-dose vial of 160 mg per 16 mL (10 mg per mL). The drug should be added to an infusion solution, and the usual dosage information can be found in the package insert. The drug should be kept out of reach of children, retained in its original packaging to protect from light, and stored between 20° to 25°C. The drug contains Doctarl, Plsrate 0N, and other ingredients. The text also contains warnings and cautions about handling the drug properly.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
